Fennec Pharmaceuticals (FENC) Notes Payables (2010 - 2017)
Fennec Pharmaceuticals' (FENC) quarterly Notes Payables came in at $167.0 million in Q4 2017, up 505960.61% YoY from N/an in Q4 2016, and up 44672.12% on a QoQ basis from $373000.0 in Q3 2017.
Fennec Pharmaceuticals (FENC) Notes Payables (2010 - 2017) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 8 years of Notes Payables data on file, last reported at $167.0 million in Q4 2017.
- Quarterly Notes Payables rose 505960.61% year-over-year to $167.0 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $167.0 million (up 505960.61% YoY) and the FY2017 annual result came in at $167.0 million, up 505960.61% from the prior year.
- Notes Payables rose to $167.0 million in Q4 2017, from $373000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $167.0 million in Q4 2017 to a low of $33000.0 in Q4 2016.
- A 5-year average of $10.2 million and a median of $533500.0 in 2015 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2015 — Notes Payables plunged 97.34% — and 2017, when it soared 505960.61%.
- Tracing FENC's Notes Payables over 5 years: stood at $2.9 million in 2013, then slumped by 53.93% to $1.3 million in 2014, then plunged by 93.78% to $82000.0 in 2015, then slumped by 59.76% to $33000.0 in 2016, then soared by 505960.61% to $167.0 million in 2017.
- The last three Notes Payables figures came in at $167.0 million (Q4 2017), $373000.0 (Q3 2017), and $190000.0 (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 167.00 Mn |
| Sep 30, 2017 | 373,000.00 |
| Jun 30, 2017 | 190,000.00 |
| Mar 31, 2017 | 71,000.00 |
| Dec 31, 2016 | 33,000.00 |
| Sep 30, 2016 | 37,000.00 |
| Jun 30, 2016 | 56,000.00 |
| Mar 31, 2016 | 39,000.00 |
| Dec 31, 2015 | 82,000.00 |
| Sep 30, 2015 | 93,000.00 |
| Jun 30, 2015 | 309,000.00 |
| Mar 31, 2015 | 694,000.00 |
| Dec 31, 2014 | 1.32 Mn |
| Sep 30, 2014 | 3.50 Mn |
| Jun 30, 2014 | 5.34 Mn |
| Mar 31, 2014 | 5.52 Mn |
| Dec 31, 2013 | 2.86 Mn |
| Sep 30, 2013 | 4.39 Mn |
| Jun 30, 2013 | 2.68 Mn |
| Mar 31, 2013 | 10.21 Mn |